Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04727866 · ClinicalTrials.gov registry record · NA

Brain Plus Spinal Stimulation for Cervical SCI

A NA study of Spinal Cord Injuries and Tetraplegia/Tetraparesis, sponsored by Bronx VA Medical Center.

Completed
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT04727866: Completed NA study of Spinal Cord Injuries and Tetraplegia/Tetraparesis, sponsored by Bronx VA Medical Center.

NCT04727866 is a NA study of Spinal Cord Injuries and Tetraplegia/Tetraparesis that has completed, run by Bronx VA Medical Center. The registered enrollment target is 24 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04727866, a NA study of Spinal Cord Injuries and Tetraplegia/Tetraparesis, has completed, sponsored by Bronx VA Medical Center.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The goal of this project is to strengthen residual corticospinal tract (CST) connections after partial injury using combined motor cortex and spinal cord stimulation to improve arm and hand function after spinal cord injury (SCI). To do this, the investigators will test the combination of transcranial magnetic stimulation (TMS) with transcutaneous spinal direct current stimulation (tsDCS) in individuals with chronic cervical SCI.

Primary Outcome

Response to transcranial magnetic stimulation in hand and forearm muscles

Interventions

  • DEVICE intermittent theta burst stimulation (iTBS)
  • DEVICE transcutaneous spinal direct current stimulation (tsDCS) - coronal
  • DEVICE transcutaneous spinal direct current stimulation (tsDCS) - caudal
  • DEVICE transcutaneous spinal direct current stimulation (tsDCS) - rostral

Study Locations (1)

New York

  • James J. Peters Veterans Affairs Medical Center - The Bronx

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-01-04
Est. Completion 2024-01-13
Phase NA
Bronx VA Medical Center

13 total trials

What the finished NCT04727866 record still lists

NCT04727866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (61% lower).

The record links to 3 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 4 interventions - of which intermittent theta burst stimulation (iTBS) is the first listed.

NCT04727866 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT04727866 about?

NCT04727866 is a clinical study titled "Brain Plus Spinal Stimulation for Cervical SCI". The goal of this project is to strengthen residual corticospinal tract (CST) connections after partial injury using combined motor cortex and spinal cord stimulation to improve arm and hand function after spinal cord injury (SCI). To do this, the investigators will test the combination of transcran...

What is the current status of trial NCT04727866?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-01-04. Estimated completion is 2024-01-13.

What conditions does trial NCT04727866 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Tetraplegia/Tetraparesis, Spinal Cord Injury at C5-C7 Level.

What interventions are being tested in trial NCT04727866?

The interventions under investigation include: intermittent theta burst stimulation (iTBS) (DEVICE), transcutaneous spinal direct current stimulation (tsDCS) - coronal (DEVICE), transcutaneous spinal direct current stimulation (tsDCS) - caudal (DEVICE), transcutaneous spinal direct current stimulation (tsDCS) - rostral (DEVICE).

Who is sponsoring clinical trial NCT04727866?

This trial is sponsored by Bronx VA Medical Center, which has 13 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04727866 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04727866's enrollment target sits among peer trials

24 114th of 202 higher than 82 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT04727866, the US trial registry maintained by the National Library of Medicine. NCT04727866 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.